LncRNAs involvement in pathogenesis of immune-related disease via regulation of T regulatory cells, an updated review

Khalilollah, Shayan; Kalantari Soltanieh, Sina; Obaid Saleh, Raed; Ali Alzahrani, Abdullah; Ghaleb Maabreh, Hatem; Mazin Al-Hamdani, Mais; Dehghani-Ghorbi, Mahmoud; Shafiei Khonachaei, Metanat; Akhavan-Sigari, Reza

doi:10.1016/j.cyto.2024.156585

Cytokine

2024

DOI: 10.1016/j.cyto.2024.156585

|View full text |Cite

LncRNAs involvement in pathogenesis of immune-related disease via regulation of T regulatory cells, an updated review

Shayan Khalilollah,

Sina Kalantari Soltanieh,

Raed Obaid Saleh

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 156 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Non-Coding RNAs in Myasthenia Gravis: From Immune Regulation to Personalized Medicine

Iacomino,

Tarasco,

Berni

et al. 2024

Cells

View full text Add to dashboard Cite

Myasthenia gravis (MG) is an antibody-mediated autoimmune disorder characterized by altered neuromuscular transmission, which causes weakness and fatigability in the skeletal muscles. The etiology of MG is complex, being associated with multiple genetic and environmental factors. Over recent years, progress has been made in understanding the immunological alterations implicated in the disease, but the exact pathogenesis still needs to be elucidated. A pathogenic interplay between innate immunity and autoimmunity contributes to the intra-thymic MG development. Epigenetic changes are critically involved in both innate and adaptive immune response regulation. They can act as (i) pathological factors besides genetic predisposition and (ii) co-factors contributing to disease phenotypes or patient-specific disease course/outcomes. This article reviews the role of non-coding RNAs (ncRNAs) as epigenetic factors implicated in MG. Particular attention is dedicated to microRNAs (miRNAs), whose expression is altered in MG patients’ thymuses and circulating blood. The long ncRNA (lncRNA) contribution to MG, although not fully characterized yet, is also discussed. By summarizing the most recent and fast-growing findings on ncRNAs in MG, we highlight the therapeutic potential of these molecules for achieving immune regulation and their value as biomarkers for the development of personalized medicine approaches to improve disease care.

show abstract

Non-Coding RNAs in Myasthenia Gravis: From Immune Regulation to Personalized Medicine

Iacomino,

Tarasco,

Berni

et al. 2024

Cells

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

LncRNAs involvement in pathogenesis of immune-related disease via regulation of T regulatory cells, an updated review

Cited by 1 publication

References 156 publications

Non-Coding RNAs in Myasthenia Gravis: From Immune Regulation to Personalized Medicine

Non-Coding RNAs in Myasthenia Gravis: From Immune Regulation to Personalized Medicine

Contact Info

Product

Resources

About